Emerging research on head and neck cancer has moved away from HPV-negative diseases upon the discovery of HPV-positive diseases, specifically HPV-positive oropharynx cancer. What do we know about managing and treating this disease? Dr. Nabile Saba dives into treatment considerations, specifically immunotherapy, for patients with HPV-positive head and neck cancer.